capillus

capillus

 [kah-pil´us] (pl. capil´li) (L.)
a hair; used in the plural to designate the aggregate of hair on the scalp.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
The Brazilian company presented Capillus Pro 22, a secondary surfactant suitable for hair care products including conditioners, masks, and repair and combing creams.
4) Adiantum capillus: It has a worldwide distribution, found in Pak-Indian subcontinent, western Himalaya, Mexico, warmer parts of America and other tropical and subtropical regions of the world (Nisar et al., 2012; Reddy, 2010).
Ltd., Korea) (n = 8); 3% topical MXD (positive control; capillus, Dong-A Pharmaceutical, Korea) (n = 7); or placebo (vehicle, 30% ethanol) (n = 8).
The HIV status of study participants was determined using the Determine HIV-1/2 (Abbott laboratories, Japan) as the screening test, the Capillus HIV-1/2 (Trinity Biotech, Ireland) as the confirmatory test and UniGold HIV-1/2 recombinant (Trinity Biotech, Ireland) as a tie breaker test [15].
Hajera, "Efficacy of Adiantum capillus veneris Linn in chemically induced urolithiasis in rats," Journal of Ethnopharmacology, vol.
With Hair Restoration as a specialty, Ritacca Cosmetic Surgery & Medspa offers Platelet Rich Plasma Therapy (PRP) for hair, red light treatments with Capillus, vitamins & supplements, FUE procedure and more performed by Dr.
The positive sera are retested by immunocombo-II Dot ELISA and Capillus latex particle agglutination method.
Afridi et al., "In vitro phytochemical, antibacterial, and antifungal activities of leaf, stem, and root extracts of Adiantum capillus veneris," The Scientific World Journal, vol.
* Alere Determine HIV 1/2 (Alere Medical Co., Ltd., Chiba, Japan), Double Check II HIV 1&2 (Orgenics Ltd., Yavne, Israel) (after February 2011 replaced by SD Bioline HIV-1/2 3.0 [Standard Diagnostics Inc., Kyonggi-do, Republic of Korea]), and Capillus HIV-1/HIV-2 (Trinity Biotech PLC, Bray, Ireland) (after November 2008 replaced by Core HIV-1&2 [Core Diagnostics, Birmingham, United Kingdom]).
HIV tests were done using the Determine (Abbott Laboratories; sensitivity 100%, specificity 98.60%) and Capillus (Trinity Biotech, Ireland; sensitivity 97.8%, specificity 99.7%) rapid test kits.